Brand family
VYVGART Hytrulo
United States
- Presentations
- 2
- Markets
- 1
VYVGART Hytrulo is a brand of Efgartigimod alfa and Hyaluronidase (human recombinant) marketed by argenx, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Efgartigimod alfa and Hyaluronidase (human recombinant)
- Brand owner
- argenx
- Registered in
- United States
- Strengths and forms
- 180 mg/2000 units per mL injection, 200 mg/2000 units per mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| VYVGART Hytrulo 180 mg/2000 units per mL injectionSubcutaneous Cold chain | argenx | US FDA | Available on request |
| VYVGART Hytrulo 200 mg/2000 units per mL injectionSubcutaneous Cold chain | argenx | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request VYVGART Hytrulo
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.